Both APCs and anti-PD-1 IMT activate CD8+ T cells in tumor-draining lymph nodes (TDLN), which subsequently traffic to the TME with the help of specific cytokines during RT combinations [48,50]. The gene discussed is CD8A; the disease is neoplasm.